ABAX Abaxis, Inc. (delisted)

UNION CITY, Calif., March 19 /PRNewswire-FirstCall/ -- Abaxis, Inc. (NASDAQ:ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, CEO and President, will present at Sidoti & Company's Twelfth Annual New York Emerging Growth Institutional Investor Forum on Tuesday, March 25, 2008 at 11:00 a.m. ET. The conference will be held at The Grand Hyatt in New York City. About Abaxis Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. Contact: Clint Severson Chief Executive Officer ABAXIS, Inc. 510-675-6500 Lytham Partners, LLC Joe Dorame, Joe Diaz & Robert Blum 602-889-9700 DATASOURCE: Abaxis, Inc. CONTACT: Clint Severson, Chief Executive Officer of Abaxis, Inc., +1-510-675-6500 or Joe Dorame, Joe Diaz & Robert Blum, of Lytham Partners, LLC, +1-602-889-9700, for Abaxis, Inc.

Copyright